Poster: Methodology - New Modelling Approaches

Accelerating robust virtual patient (VP) population generation by substituting ODE solving with simple parameter comparisons

Thursday 16 October, 2025

Introduction/Objectives: The generation of Virtual Patients (VPs) is a common task in Quantitative System Pharmacology (QSP). In the most classical…

Read more

A method to estimate probability of disease and vaccine efficacy from clinical trial immunogenicity data

Thursday 16 October, 2025

Introduction: Protective efficacy of a vaccine is defined as the proportional reduction in risk of disease among vaccinated subjects compared…

Read more

Survival Model-based Meta-Analysis Framework for the Indirect Comparison of Anti-Cancer Therapy Efficacy

Thursday 16 October, 2025

Introduction: Overall Survival (OS) is a gold standard clinical endpoint to assess efficacy of anticancer therapies. However, direct comparison of…

Read more

Validation of a Semi-mechanistic model with first-pass metabolism, two metabolic pathways and intestinal efflux transporter implemented in PhysPK biosimulation software.

Thursday 16 October, 2025

Objectives: The aim of this work is to validate model predictions from PhysPK biosimulation software using a previously published semi-mechanistic…

Read more

The dynamics of pharmacological effects aimed at gut wall: A framework for a nested-target-within-enterocyte (NTWE) model that accounts for turnover of target and cell

Thursday 16 October, 2025

Introduction: The gastrointestinal (GI) tract has been the focus of several potential therapeutic target linked to metabolic diseases, cancer, inflammatory…

Read more

Statistical interaction modeling in non-linear mixed effect models: a case study in neonatal pharmacology

Thursday 16 October, 2025

Introduction Covariate analysis is a crucial step in nonlinear mixed-effects (NLME) modeling to enable individualized dose and treatment optimization. Covariates…

Read more

Hierarchical group LASSO with random effects: identification of high-dimensional omics-drug interactions predictive of treatment response in patient-derived tumor growth data

Thursday 16 October, 2025

Objectives: High-dimensional molecular profiling technologies (‘omics’) including genomics and transcriptomics are rapidly emerging as promising approach to personalize drug treatments….

Read more

Modeling (a)symmetry of concentration-effect curves

Thursday 16 October, 2025

Introduction: An important topic in quantitative pharmacology is modeling the shape of concentration- effect (E/[A]) curves, which relate the concentration…

Read more

Neural Ordinary Differential Equations for Tumor Dynamics Modeling and Overall Survival Predictions

Thursday 16 October, 2025

Introduction: Tumor dynamic modeling has been widely adopted in supporting the development of oncology drugs. While the existing Tumor Growth…

Read more

Pharmacokinetic Model Based on Stochastic Simulation and Estimation for Therapeutic Drug Monitoring of Tacrolimus in Korean Adult Transplant Recipients

Thursday 16 October, 2025

Objectives: Tacrolimus shows high variability in inter- and intra-individual pharmacokinetics (PK); therefore, it is important to develop an appropriate model…

Read more